Evelo Biosciences Announces $25.5 Million Private Placement

<p>CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis (SINTAX), today announced that it has entered into a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/evelo-biosciences-announces-25-5-million-private-placement/">Evelo Biosciences Announces $25.5 Million Private Placement</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>